284 related articles for article (PubMed ID: 35645097)
21. Microwave ablation compared with radiofrequency ablation for the treatment of liver cancer: a systematic review and meta-analysis.
Spiliotis AE; Gäbelein G; Holländer S; Scherber PR; Glanemann M; Patel B
Radiol Oncol; 2021 Jun; 55(3):247-258. PubMed ID: 34167181
[TBL] [Abstract][Full Text] [Related]
22. Long-term outcomes of microwave versus radiofrequency ablation for hepatocellular carcinoma by surgical approach: A retrospective comparative study.
Lee KF; Wong J; Hui JW; Cheung YS; Chong CC; Fong AK; Yu SC; Lai PB
Asian J Surg; 2017 Jul; 40(4):301-308. PubMed ID: 26922631
[TBL] [Abstract][Full Text] [Related]
23. Percutaneous microwave ablation versus radiofrequency ablation of hepatocellular carcinoma: a meta-analysis of randomized controlled trials.
Yu Q; Liu C; Navuluri R; Ahmed O
Abdom Radiol (NY); 2021 Sep; 46(9):4467-4475. PubMed ID: 33870454
[TBL] [Abstract][Full Text] [Related]
24. Percutaneous thermal ablation of primary and secondary lung tumors: Comparison between microwave and radiofrequency ablation.
Aufranc V; Farouil G; Abdel-Rehim M; Smadja P; Tardieu M; Aptel S; Guibal A
Diagn Interv Imaging; 2019 Dec; 100(12):781-791. PubMed ID: 31402333
[TBL] [Abstract][Full Text] [Related]
25. Microwave ablation versus radiofrequency ablation for perivascular hepatocellular carcinoma: a propensity score analysis.
Feng Y; Wang L; Lv H; Shi T; Xu C; Zheng H; Qi J; Zhao X; Li J; Gao Y; Qin C; Zhu Q
HPB (Oxford); 2021 Apr; 23(4):512-519. PubMed ID: 32839089
[TBL] [Abstract][Full Text] [Related]
26. Comparison of radiofrequency and microwave ablation and identification of risk factors for primary treatment failure and local progression.
McDevitt JL; Collard MD; Murphy RP; Sutphin PD; Yopp AC; Singal AG; Kalva SP
Clin Imaging; 2020 Nov; 67():146-151. PubMed ID: 32659600
[TBL] [Abstract][Full Text] [Related]
27. Ultrasound-guided percutaneous microwave ablation for hepatocellular carcinoma originating in the caudate lobe: A pilot clinical study.
Peng Y; Cui D; Li W; Ding M; Shi Y; Wang T; Shi D; Chi J; Li P; Zhai B
J Cancer Res Ther; 2021 Jul; 17(3):764-770. PubMed ID: 34269311
[TBL] [Abstract][Full Text] [Related]
28. Current use of percutaneous image-guided tumor ablation for the therapy of liver tumors: lessons learned from the registry of the German Society for Interventional Radiology and Minimally Invasive Therapy (DeGIR) 2018-2022.
Zensen S; Bücker A; Meetschen M; Haubold J; Opitz M; Theysohn JM; Schramm S; Jochheim L; Kasper S; Forsting M; Schaarschmidt BM
Eur Radiol; 2024 May; 34(5):3322-3330. PubMed ID: 37935847
[TBL] [Abstract][Full Text] [Related]
29. Combined radiofrequency ablation or microwave ablation with transarterial chemoembolization can increase efficiency in intermediate-stage hepatocellular carcinoma without more complication: a systematic review and meta-analysis.
Yang Y; Yu H; Qi L; Liu C; Feng Y; Qi J; Li J; Zhu Q
Int J Hyperthermia; 2022; 39(1):455-465. PubMed ID: 35271786
[TBL] [Abstract][Full Text] [Related]
30. Transarterial chemoembolization combined with microwave ablation versus microwave ablation only for Barcelona clinic liver cancer Stage B hepatocellular carcinoma: A propensity score matching study.
Li X; Chen B; An C; Cheng Z; Han Z; Liu F; Yu J; Liang P
J Cancer Res Ther; 2020 Sep; 16(5):1027-1037. PubMed ID: 33004744
[TBL] [Abstract][Full Text] [Related]
31. Percutaneous microwave ablation for hepatocellular carcinoma adjacent to large vessels: a long-term follow-up.
Huang S; Yu J; Liang P; Yu X; Cheng Z; Han Z; Li Q
Eur J Radiol; 2014 Mar; 83(3):552-8. PubMed ID: 24418287
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma in patients with chronic liver disease: a randomised controlled phase 2 trial.
Vietti Violi N; Duran R; Guiu B; Cercueil JP; Aubé C; Digklia A; Pache I; Deltenre P; Knebel JF; Denys A
Lancet Gastroenterol Hepatol; 2018 May; 3(5):317-325. PubMed ID: 29503247
[TBL] [Abstract][Full Text] [Related]
33. SAGES/AHPBA guidelines for the use of microwave and radiofrequency liver ablation for the surgical treatment of hepatocellular carcinoma or colorectal liver metastases less than 5 cm.
Ceppa EP; Collings AT; Abdalla M; Onkendi E; Nelson DW; Ozair A; Miraflor E; Rahman F; Whiteside J; Shah MM; Ayloo S; Dirks R; Kumar SS; Ansari MT; Sucandy I; Ali K; Douglas S; Polanco PM; Vreeland TJ; Buell J; Abou-Setta AM; Awad Z; Kwon CH; Martinie JB; Sbrana F; Pryor A; Slater BJ; Richardson W; Jeyarajah R; Alseidi A
Surg Endosc; 2023 Dec; 37(12):8991-9000. PubMed ID: 37957297
[TBL] [Abstract][Full Text] [Related]
34. Microwave versus radiofrequency ablation for the treatment of liver malignancies: a randomized controlled phase 2 trial.
Radosevic A; Quesada R; Serlavos C; Sánchez J; Zugazaga A; Sierra A; Coll S; Busto M; Aguilar G; Flores D; Arce J; Maiques JM; Garcia-Retortillo M; Carrion JA; Visa L; Villamonte M; Pueyo E; Berjano E; Trujillo M; Sánchez-Velázquez P; Grande L; Burdio F
Sci Rep; 2022 Jan; 12(1):316. PubMed ID: 35013377
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and survival analysis of percutaneous radiofrequency versus microwave ablation for hepatocellular carcinoma: an Egyptian multidisciplinary clinic experience.
Abdelaziz A; Elbaz T; Shousha HI; Mahmoud S; Ibrahim M; Abdelmaksoud A; Nabeel M
Surg Endosc; 2014 Dec; 28(12):3429-34. PubMed ID: 24935203
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of microwave ablation versus radiofrequency ablation in the treatment of colorectal liver metastases: A systematic review and meta-analysis.
Tang Y; Zhong H; Wang Y; Wu J; Zheng J
Clin Res Hepatol Gastroenterol; 2023 Aug; 47(7):102182. PubMed ID: 37479137
[TBL] [Abstract][Full Text] [Related]
37. Safety and efficacy of RFA versus MWA for T1a renal cell carcinoma: a propensity score analysis.
Aarts BM; Gomez FM; Lopez-Yurda M; Bevers RFM; Herndriks J; Beets-Tan RGH; Bex A; Klompenhouwer EG; van der Meer RW
Eur Radiol; 2023 Feb; 33(2):1040-1049. PubMed ID: 36066733
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of microwave ablation and radiofrequency ablation in the treatment of hepatocellular carcinoma: A systematic review and meta-analysis.
Dou Z; Lu F; Ren L; Song X; Li B; Li X
Medicine (Baltimore); 2022 Jul; 101(30):e29321. PubMed ID: 35905207
[TBL] [Abstract][Full Text] [Related]
39. Surgical approach to microwave and radiofrequency liver ablation for hepatocellular carcinoma and colorectal liver metastases less than 5 cm: a systematic review and meta-analysis.
Abdalla M; Collings AT; Dirks R; Onkendi E; Nelson D; Ozair A; Miraflor E; Rahman F; Whiteside J; Shah MM; Ayloo S; Abou-Setta A; Sucandy I; Kchaou A; Douglas S; Polanco P; Vreeland T; Buell J; Ansari MT; Pryor AD; Slater BJ; Awad Z; Richardson W; Alseidi A; Jeyarajah DR; Ceppa E
Surg Endosc; 2023 May; 37(5):3340-3353. PubMed ID: 36542137
[TBL] [Abstract][Full Text] [Related]
40. Image-guided microwave ablation of hepatocellular carcinoma (≤5.0 cm): is MR guidance more effective than CT guidance?
Li Z; Wang C; Si G; Zhou X; Li Y; Li J; Jiao D; Han X
BMC Cancer; 2021 Apr; 21(1):366. PubMed ID: 33827464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
